Menu

Skip to content
  • Home
  • People
  • Research
    • Influenza Virus
    • Oncolytic Viruses
    • Type I IFN
    • Viral IFN Antagonists
  • Publications
  • Contact

Garcia-Sastre Laboratory 

icahn.mssm.edu   /   Inside Mount Sinai Blog

Menu

Skip to content
  • Home
  • People
  • Research
    • Influenza Virus
    • Oncolytic Viruses
    • Type I IFN
    • Viral IFN Antagonists
  • Publications
  • Contact

Rebecca Pearl

Associate Researcher
rebecca.pearl@mssm.edu

 

 

 

 

 

 

 

RSS Recent Publications

  • Outburst of serotype 4 IPD after COVID-19 is driven by ST15063/GPSC162 lineage associated with high-risk behaviors and greater virulence linked to influenza H3N2 virus coinfection and cigarette smoke March 23, 2026 Covadonga Pérez-García
  • Divergent macrophage responses to Influenza A virus and <em>Streptococcus pneumoniae</em>: co-infection drives bacterial dominance whereas superinfection favors viral priming March 20, 2026 Javier Arranz-Herrero
  • Compartmentalized cytokine networks and systemic immune remodeling in bovine mammary H5N1 infection March 18, 2026 Gagandeep Singh
  • Early Fc-effector antibody signatures impact COVID-19 disease trajectory February 27, 2026 Alba Escalera
  • Dose-dependent IFN programs in myeloid cells after mRNA and adenovirus COVID-19 vaccination February 23, 2026 Giray Eryilmaz
  • Cross-reactivity between antibodies induced by European swine influenza vaccines and Spanish swine influenza strains February 20, 2026 Paloma Encinas
  • Longitudinal Surveillance of Influenza A Virus Exposure in Wild Boars (Sus scrofa) in Spain (2015-2023): Serologic and Virologic Evidence of Subtype Infections and H5N1 Spillover Risk February 11, 2026 Paloma Encinas
  • Influenza hijacks myeloid cells to inflict type-I interferon-fueled damage in the heart February 10, 2026 Jeffrey Downey
  • MHC class II functions as a host-specific entry receptor for representative human and swine H3N2 influenza A viruses February 10, 2026 Matias Cardenas
  • A bireporter recombinant SARS-CoV-2 Omicron BA.5 for <em>in vitro</em> and <em>in vivo</em> studies February 9, 2026 Esteban M Castro
  • Prenatal and postnatal effects of gestational immune activation on synaptic and neurodevelopmental pathways via epigenetic mechanisms February 7, 2026 Bohan Zhu
  • Immunogenicity and efficacy of a rabies-based vaccine against highly pathogenic influenza H5N1 virus January 20, 2026 Nir Paran
  • STING activation by teniposide: a potential direct mechanism beyond cGAS stimulation January 19, 2026 Javier Arranz-Herrero
  • Coevolutionary constraints of Zika virus nonstructural protein 5 replication and interferon antagonism activities January 9, 2026 R Blake Richardson
  • Discovery of Coronavirus Main Protease Inhibitors with Enhanced Brain Exposure and Potent Oral Efficacy in SARS-CoV-2 and MERS Infection Models January 6, 2026 Luca Lizzadro

Upcoming Events

Click here to view a calendar with upcoming events.

Careers | Contact Us | Privacy | Legal
800-MD-SINAI
© Icahn School of Medicine at Mount Sinai